Tactile Systems reports Q3 EPS (11c), consensus (8c)

Reports Q3 revenue $65.26M, consensus $60.05M. "We are excited to deliver total revenue performance that exceeded our expectations for the third quarter," said Dan Reuvers, president and CEO of Tactile Medical. "Sales of our airway clearance products benefited from strong demand by our DME channel partners, as their sales reps continued to adopt our technology and identify patients in need of treatment among their existing customers. In our lymphedema business, we were pleased to see improvement in patient volumes at the clinics we serve, along with a positive initial response following the full market release of our ComfortEase garments. Importantly, in addition to our strong sales performance, we also delivered significant improvements in our profitability, increasing our gross, operating and adjusted EBITDA margins compared to the prior year quarter."